Lack of efficacy of a double autograft program to prolong survival of chronic myelogenous leukemia patients in blastic transformation

Haematologica

Volumn 81, Issue 4, 1996, Pages 349-351

  Capria, Saveria ^a   Vignetti, Marco ^a   Montefusco, Enrico ^a   Cardillo, Antonietta M F ^a   Simone, Francesca ^a   Meloni, Giovanna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic myelogenous leukemia; Double autograft

Indexed keywords

ADULT; ARTICLE; AUTOGRAFT; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0030323928     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Buckner CD, Clift RA, Fefer A, Neiman PE, Storb R, Thomas ED. Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow. Exp Hematol 1974; 2:138-46.
2. Goldman JM, Johnson SA, Catowsky D, Wareham NJ, Galton DAG. Autografting for chronic granulocytic leukemia. N Engl J Med 1981b; 304:700.
3. Reiffers J, Vezon G, Bernard Ph, et al. Haemopoietic stem cell autografting for chronic granulocytic leukemia in transformation. Exp Hematol 1983; 11:148-9.
4. Haines ME., Goldman JM, Worsley AM, et al. Chemotherapy and autografting for chronic granulocytic leukemia in transformation: probable prolongation of survival for some patients. Br J Haematol 1984; 58:711-21.
5. Reiffers J, Trouette R, Marit G, et al. Autologous blood stem cell transplantation for chronic granulocytic leukemia in transformation: a report of 47 cases. Br J Haematol 1991; 77: 339-45.
6. Barnett MJ, Eaves CJ, Phillips JL et al. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood 1994; 84:724-32.
7. Carella AM, Frassoni F, Negrin RS. Autografting in chronic myelogenous leukemia: new questions. Leukemia 1995; 9: 365-9.
8. Martinelli G, Lemoli RM, Farabegoli P, et al. Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Haematologica 1994; 79:445-7.
9. Meloni G, Vignetti M, De Fabritiis P, et al. Autograft followed by α-IFN for chronic myelogenous leukemia in chronic phase. Bone Marrow Transpl 1994; 14 (suppl. 3): S82.
10. De Fabritiis P, Sandrelli A, Meloni G et al. Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transpl 1990;6:247-51.
11. Meloni G, Pinto RM., De Fabritiis P, et al. Ablative chemotherapy followed by peripheral blood stem cell reinfusion for chronic myelogenous leukemia in chronic phase. Int J Cell Cloning 1992; 10(suppl.1): 124-7.
12. De Fabritiis P, Calabretta B. Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? Haematologica 1995; 80:295-9.